Sleep duration does not mediate or modify association of common genetic variants with type 2 diabetes

Archana Tare; Jacqueline M. Lane; Brian E. Cade; Struan F.A. Grant; Ting Hsu Chen; Naresh M. Punjabi; Diane S. Lauderdale; Phyllis C. Zee; Sina A. Gharib; Daniel J. Gottlieb; Frank A.J.L. Scheer; Susan Redline; Richa Saxena

doi:10.1007/s00125-013-3110-y

Sleep duration does not mediate or modify association of common genetic variants with type 2 diabetes

Archana Tare, Jacqueline M. Lane, Brian E. Cade, Struan F.A. Grant, Ting Hsu Chen, Naresh M. Punjabi, Diane S. Lauderdale, Phyllis C. Zee, Sina A. Gharib, Daniel J. Gottlieb, Frank A.J.L. Scheer, Susan Redline, Richa Saxena

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Aims/hypothesis: Short and long sleep duration are associated with increased risk of type 2 diabetes. We aimed to investigate whether genetic variants for fasting glucose or type 2 diabetes associate with short or long sleep duration and whether sleep duration modifies the association of genetic variants with these traits. Methods: We examined the cross-sectional relationship between self-reported habitual sleep duration and prevalence of type 2 diabetes in individuals of European descent participating in five studies included in the Candidate Gene Association Resource (CARe), totalling 1,474 cases and 8,323 controls. We tested for association of 16 fasting glucose-associated variants, 27 type 2 diabetes-associated variants and aggregate genetic risk scores with continuous and dichotomised (≤5 h or ≥9 h) sleep duration using regression models adjusted for age, sex and BMI. Finally, we tested whether a gene × behaviour interaction of variants with sleep duration had an impact on fasting glucose or type 2 diabetes risk. Results: Short sleep duration was significantly associated with type 2 diabetes in CARe (OR 1.32; 95% CI 1.08, 1.61; p = 0.008). Variants previously associated with fasting glucose or type 2 diabetes and genetic risk scores were not associated with sleep duration. Furthermore, no study-wide significant interaction was observed between sleep duration and these variants on glycaemic traits. Nominal interactions were observed for sleep duration and PPARG rs1801282, CRY2 rs7943320 and HNF1B rs4430796 in influencing risk of type 2 diabetes (p < 0.05). Conclusions/interpretation: Our findings suggest that differences in habitual sleep duration do not mediate or modify the relationship between common variants underlying glycaemic traits (including in circadian rhythm genes) and diabetes.

Original language	English (US)
Pages (from-to)	339-346
Number of pages	8
Journal	Diabetologia
Volume	57
Issue number	2
DOIs	https://doi.org/10.1007/s00125-013-3110-y
State	Published - Feb 2014
Externally published	Yes

Keywords

Circadian genes
Genetic association studies
Genetic risk score
Sleep duration
Type 2 diabetes

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s00125-013-3110-y

Cite this

Tare, A., Lane, J. M., Cade, B. E., Grant, S. F. A., Chen, T. H., Punjabi, N. M., Lauderdale, D. S., Zee, P. C., Gharib, S. A., Gottlieb, D. J., Scheer, F. A. J. L., Redline, S., & Saxena, R. (2014). Sleep duration does not mediate or modify association of common genetic variants with type 2 diabetes. Diabetologia, 57(2), 339-346. https://doi.org/10.1007/s00125-013-3110-y

@article{a96f240445014792a01b4c174c4c90c6,

title = "Sleep duration does not mediate or modify association of common genetic variants with type 2 diabetes",

abstract = "Aims/hypothesis: Short and long sleep duration are associated with increased risk of type 2 diabetes. We aimed to investigate whether genetic variants for fasting glucose or type 2 diabetes associate with short or long sleep duration and whether sleep duration modifies the association of genetic variants with these traits. Methods: We examined the cross-sectional relationship between self-reported habitual sleep duration and prevalence of type 2 diabetes in individuals of European descent participating in five studies included in the Candidate Gene Association Resource (CARe), totalling 1,474 cases and 8,323 controls. We tested for association of 16 fasting glucose-associated variants, 27 type 2 diabetes-associated variants and aggregate genetic risk scores with continuous and dichotomised (≤5 h or ≥9 h) sleep duration using regression models adjusted for age, sex and BMI. Finally, we tested whether a gene × behaviour interaction of variants with sleep duration had an impact on fasting glucose or type 2 diabetes risk. Results: Short sleep duration was significantly associated with type 2 diabetes in CARe (OR 1.32; 95% CI 1.08, 1.61; p = 0.008). Variants previously associated with fasting glucose or type 2 diabetes and genetic risk scores were not associated with sleep duration. Furthermore, no study-wide significant interaction was observed between sleep duration and these variants on glycaemic traits. Nominal interactions were observed for sleep duration and PPARG rs1801282, CRY2 rs7943320 and HNF1B rs4430796 in influencing risk of type 2 diabetes (p < 0.05). Conclusions/interpretation: Our findings suggest that differences in habitual sleep duration do not mediate or modify the relationship between common variants underlying glycaemic traits (including in circadian rhythm genes) and diabetes.",

keywords = "Circadian genes, Genetic association studies, Genetic risk score, Sleep duration, Type 2 diabetes",

author = "Archana Tare and Lane, {Jacqueline M.} and Cade, {Brian E.} and Grant, {Struan F.A.} and Chen, {Ting Hsu} and Punjabi, {Naresh M.} and Lauderdale, {Diane S.} and Zee, {Phyllis C.} and Gharib, {Sina A.} and Gottlieb, {Daniel J.} and Scheer, {Frank A.J.L.} and Susan Redline and Richa Saxena",

note = "Funding Information: Funding This study was conducted with support to RS and FAJLS from NIDDK NIH R21 (DK089378) and from Harvard Catalyst of the Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05 and financial contributions from Harvard University and its affiliated academic healthcare centres). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centres or the National Institutes of Health. CARe and SHHS are supported by the National Heart, Lung, and Blood Institute cooperative agreement U01HL53941 (Boston University), U01HL53916 (University of California, Davis), U01HL53934 (University of Minnesota), U01HL 53937 and U01HL63429 (Johns Hopkins University) and U01HL 63463 (Case Western Reserve University). The CHS was supported by NHLBI contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083 and N01HC85086 and by NHLBI grants HL080295, HL087652 and HL105756, with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through AG023629 from the National Institute on Aging (NIA). A full list of CHS principal investigators and institutions can be found at www.chs-nhlbi.org/pi.",

year = "2014",

month = feb,

doi = "10.1007/s00125-013-3110-y",

language = "English (US)",

volume = "57",

pages = "339--346",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Sleep duration does not mediate or modify association of common genetic variants with type 2 diabetes

AU - Tare, Archana

AU - Lane, Jacqueline M.

AU - Cade, Brian E.

AU - Grant, Struan F.A.

AU - Chen, Ting Hsu

AU - Punjabi, Naresh M.

AU - Lauderdale, Diane S.

AU - Zee, Phyllis C.

AU - Gharib, Sina A.

AU - Gottlieb, Daniel J.

AU - Scheer, Frank A.J.L.

AU - Redline, Susan

AU - Saxena, Richa

N1 - Funding Information: Funding This study was conducted with support to RS and FAJLS from NIDDK NIH R21 (DK089378) and from Harvard Catalyst of the Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05 and financial contributions from Harvard University and its affiliated academic healthcare centres). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centres or the National Institutes of Health. CARe and SHHS are supported by the National Heart, Lung, and Blood Institute cooperative agreement U01HL53941 (Boston University), U01HL53916 (University of California, Davis), U01HL53934 (University of Minnesota), U01HL 53937 and U01HL63429 (Johns Hopkins University) and U01HL 63463 (Case Western Reserve University). The CHS was supported by NHLBI contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083 and N01HC85086 and by NHLBI grants HL080295, HL087652 and HL105756, with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through AG023629 from the National Institute on Aging (NIA). A full list of CHS principal investigators and institutions can be found at www.chs-nhlbi.org/pi.

PY - 2014/2

Y1 - 2014/2

N2 - Aims/hypothesis: Short and long sleep duration are associated with increased risk of type 2 diabetes. We aimed to investigate whether genetic variants for fasting glucose or type 2 diabetes associate with short or long sleep duration and whether sleep duration modifies the association of genetic variants with these traits. Methods: We examined the cross-sectional relationship between self-reported habitual sleep duration and prevalence of type 2 diabetes in individuals of European descent participating in five studies included in the Candidate Gene Association Resource (CARe), totalling 1,474 cases and 8,323 controls. We tested for association of 16 fasting glucose-associated variants, 27 type 2 diabetes-associated variants and aggregate genetic risk scores with continuous and dichotomised (≤5 h or ≥9 h) sleep duration using regression models adjusted for age, sex and BMI. Finally, we tested whether a gene × behaviour interaction of variants with sleep duration had an impact on fasting glucose or type 2 diabetes risk. Results: Short sleep duration was significantly associated with type 2 diabetes in CARe (OR 1.32; 95% CI 1.08, 1.61; p = 0.008). Variants previously associated with fasting glucose or type 2 diabetes and genetic risk scores were not associated with sleep duration. Furthermore, no study-wide significant interaction was observed between sleep duration and these variants on glycaemic traits. Nominal interactions were observed for sleep duration and PPARG rs1801282, CRY2 rs7943320 and HNF1B rs4430796 in influencing risk of type 2 diabetes (p < 0.05). Conclusions/interpretation: Our findings suggest that differences in habitual sleep duration do not mediate or modify the relationship between common variants underlying glycaemic traits (including in circadian rhythm genes) and diabetes.

AB - Aims/hypothesis: Short and long sleep duration are associated with increased risk of type 2 diabetes. We aimed to investigate whether genetic variants for fasting glucose or type 2 diabetes associate with short or long sleep duration and whether sleep duration modifies the association of genetic variants with these traits. Methods: We examined the cross-sectional relationship between self-reported habitual sleep duration and prevalence of type 2 diabetes in individuals of European descent participating in five studies included in the Candidate Gene Association Resource (CARe), totalling 1,474 cases and 8,323 controls. We tested for association of 16 fasting glucose-associated variants, 27 type 2 diabetes-associated variants and aggregate genetic risk scores with continuous and dichotomised (≤5 h or ≥9 h) sleep duration using regression models adjusted for age, sex and BMI. Finally, we tested whether a gene × behaviour interaction of variants with sleep duration had an impact on fasting glucose or type 2 diabetes risk. Results: Short sleep duration was significantly associated with type 2 diabetes in CARe (OR 1.32; 95% CI 1.08, 1.61; p = 0.008). Variants previously associated with fasting glucose or type 2 diabetes and genetic risk scores were not associated with sleep duration. Furthermore, no study-wide significant interaction was observed between sleep duration and these variants on glycaemic traits. Nominal interactions were observed for sleep duration and PPARG rs1801282, CRY2 rs7943320 and HNF1B rs4430796 in influencing risk of type 2 diabetes (p < 0.05). Conclusions/interpretation: Our findings suggest that differences in habitual sleep duration do not mediate or modify the relationship between common variants underlying glycaemic traits (including in circadian rhythm genes) and diabetes.

KW - Circadian genes

KW - Genetic association studies

KW - Genetic risk score

KW - Sleep duration

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84893657538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893657538&partnerID=8YFLogxK

U2 - 10.1007/s00125-013-3110-y

DO - 10.1007/s00125-013-3110-y

M3 - Article

C2 - 24280871

AN - SCOPUS:84893657538

SN - 0012-186X

VL - 57

SP - 339

EP - 346

JO - Diabetologia

JF - Diabetologia

IS - 2

ER -

Sleep duration does not mediate or modify association of common genetic variants with type 2 diabetes

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this